Literature DB >> 15660034

Prognostic impact of body weight and abdominal obesity in women and men with cardiovascular disease.

Gilles R Dagenais1, Qilong Yi, Johannes F E Mann, Jackie Bosch, Janice Pogue, Salim Yusuf.   

Abstract

BACKGROUND: Increased body mass index (BMI) and abdominal adiposity increase the risk of cardiovascular disease (CVD) in persons free of these diseases, but their independent prognostic impact in persons with CVD has not been well defined.
METHODS: BMI, waist-to-hip ratio (WHR), and waist circumference (WC) were measured in 6620 men and 2182 women with a mean age of 66 and stable CVD without congestive heart failure (CHF) participating in the Heart Outcomes Prevention Evaluation (HOPE) study. The main outcomes were CVD death, myocardial infarction, stroke, hospitalization for CHF, and all-cause mortality.
RESULTS: During the 4.5-year follow-up, 658 had a CVD death, 1018 a myocardial infarction, 364 a stroke, 297 a CHF event, and 1034 died. When compared with the first tertile, the third tertile of BMI increased the adjusted relative risk (RR) of myocardial infarction by 20% (P < .02). Patients in the third tertile of WC had an increased adjusted RR of 23% for myocardial infarction (P < .01), 38% for heart failure (P < .03), and 17% for total mortality (P < .05). For WHR, there was an increased adjusted RR of 24% for CVD death (P < .03), 20% for myocardial infarction (P < .01), and 32% for total mortality (P < .001).
CONCLUSIONS: Obesity, particularly abdominal adiposity, worsens the prognosis of patients with CVD; weight reduction program should be integrated in the active management of these patients.

Entities:  

Mesh:

Year:  2005        PMID: 15660034     DOI: 10.1016/j.ahj.2004.07.009

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  68 in total

Review 1.  Glycemic control and weight reduction without causing hypoglycemia: the case for continued safe aggressive care of patients with type 2 diabetes mellitus and avoidance of therapeutic inertia.

Authors:  Stanley S Schwartz; Benjamin A Kohl
Journal:  Mayo Clin Proc       Date:  2010-11-24       Impact factor: 7.616

Review 2.  Basic science: Pathophysiology: the cardiorenal metabolic syndrome.

Authors:  Adam Whaley-Connell; James R Sowers
Journal:  J Am Soc Hypertens       Date:  2014-07-05

3.  Physician diagnosis of overweight status predicts attempted and successful weight loss in patients with cardiovascular disease and central obesity.

Authors:  Siddharth Singh; Virend K Somers; Matthew M Clark; Kristin Vickers; Donald D Hensrud; Yoel Korenfeld; Francisco Lopez-Jimenez
Journal:  Am Heart J       Date:  2010-11       Impact factor: 4.749

4.  Adiposity and incident heart failure in older adults: the cardiovascular health study.

Authors:  Luc Djoussé; Traci M Bartz; Joachim H Ix; Susan J Zieman; Joseph A Delaney; Kenneth J Mukamal; John S Gottdiener; David S Siscovick; Jorge R Kizer
Journal:  Obesity (Silver Spring)       Date:  2011-10-20       Impact factor: 5.002

5.  Longitudinal examination of obesity and cognitive function: results from the Baltimore longitudinal study of aging.

Authors:  John Gunstad; April Lhotsky; Carrington Rice Wendell; Luigi Ferrucci; Alan B Zonderman
Journal:  Neuroepidemiology       Date:  2010-03-18       Impact factor: 3.282

Review 6.  Does sustained weight loss reverse the metabolic syndrome?

Authors:  Annie Ferland; Robert H Eckel
Journal:  Curr Hypertens Rep       Date:  2011-12       Impact factor: 5.369

Review 7.  Cushing's disease.

Authors:  Martina De Martin; Francesca Pecori Giraldi; Francesco Cavagnini
Journal:  Pituitary       Date:  2006       Impact factor: 4.107

8.  Body Mass Index Predicts 24-Hour Urinary Aldosterone Levels in Patients With Resistant Hypertension.

Authors:  Tanja Dudenbostel; Lama Ghazi; Mingchun Liu; Peng Li; Suzanne Oparil; David A Calhoun
Journal:  Hypertension       Date:  2016-08-15       Impact factor: 10.190

9.  Canadian Cardiovascular Society Consensus Conference guidelines on heart failure--2008 update: best practices for the transition of care of heart failure patients, and the recognition, investigation and treatment of cardiomyopathies.

Authors:  J Malcom; O Arnold; Jonathan G Howlett; Anique Ducharme; Justin A Ezekowitz; Martin J Gardner; Nadia Giannetti; Haissam Haddad; George A Heckman; Debra Isaac; Philip Jong; Peter Liu; Elizabeth Mann; Robert S McKelvie; Gordon W Moe; Anna M Svendsen; Ross T Tsuyuki; Kelly O'Halloran; Heather J Ross; Errol J Sequeira; Michel White
Journal:  Can J Cardiol       Date:  2008-01       Impact factor: 5.223

10.  Inverse association of erythrocyte n-3 fatty acid levels with inflammatory biomarkers in patients with stable coronary artery disease: The Heart and Soul Study.

Authors:  Ramin Farzaneh-Far; William S Harris; Sachin Garg; Beeya Na; Mary A Whooley
Journal:  Atherosclerosis       Date:  2008-12-14       Impact factor: 5.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.